Literature DB >> 23180177

4-Aminopyridine suppresses positional nystagmus caused by cerebellar vermis lesion.

O Kremmyda, A Zwergal, C la Fougère, T Brandt, K Jahn, M Strupp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180177     DOI: 10.1007/s00415-012-6737-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

Review 1.  Diagnostic criteria for central versus peripheral positioning nystagmus and vertigo: a review.

Authors:  U Büttner; C Helmchen; T Brandt
Journal:  Acta Otolaryngol       Date:  1999-01       Impact factor: 1.494

2.  Posterior vermal Purkinje cells in macaques responding during saccades, smooth pursuit, chair rotation and/or optokinetic stimulation.

Authors:  H Sato; H Noda
Journal:  Neurosci Res       Date:  1992-01       Impact factor: 3.304

3.  A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.

Authors:  M Strupp; R Kalla; J Claassen; C Adrion; U Mansmann; T Klopstock; T Freilinger; H Neugebauer; R Spiegel; M Dichgans; F Lehmann-Horn; K Jurkat-Rott; T Brandt; J C Jen; K Jahn
Journal:  Neurology       Date:  2011-07-06       Impact factor: 9.910

4.  The mechanism of downbeat nystagmus.

Authors:  D S Zee; A R Friendlich; D A Robinson
Journal:  Arch Neurol       Date:  1974-03

Review 5.  Afferent and efferent connections of the oculomotor cerebellar vermis in the macaque monkey.

Authors:  J Yamada; H Noda
Journal:  J Comp Neurol       Date:  1987-11-08       Impact factor: 3.215

6.  Downbeating nystagmus. A review of 62 cases.

Authors:  G M Halmagyi; P Rudge; M A Gresty; M D Sanders
Journal:  Arch Neurol       Date:  1983-12

7.  Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells.

Authors:  Y Etzion; Y Grossman
Journal:  Exp Brain Res       Date:  2001-08       Impact factor: 1.972

8.  Positional vertigo and the cerebellar vermis.

Authors:  J C Kattah; M P Kolsky; A J Luessenhop
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

9.  Gravity dependence of ocular drift in patients with cerebellar downbeat nystagmus.

Authors:  Sarah Marti; Antonella Palla; Dominik Straumann
Journal:  Ann Neurol       Date:  2002-12       Impact factor: 10.422

10.  Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.

Authors:  M Strupp; O Schüler; S Krafczyk; K Jahn; F Schautzer; U Büttner; T Brandt
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

  10 in total
  11 in total

Review 1.  The treatment and natural course of peripheral and central vertigo.

Authors:  Michael Strupp; Marianne Dieterich; Thomas Brandt
Journal:  Dtsch Arztebl Int       Date:  2013-07-22       Impact factor: 5.594

Review 2.  Neuro-ophthalmology update.

Authors:  Konrad P Weber; Dominik Straumann
Journal:  J Neurol       Date:  2013-09-26       Impact factor: 4.849

Review 3.  Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.

Authors:  Katharina Feil; Tatiana Bremova; Carolin Muth; Roman Schniepp; Julian Teufel; Michael Strupp
Journal:  Cerebellum       Date:  2016-02       Impact factor: 3.847

Review 4.  [Vertigo and dizziness in the emergency room].

Authors:  A Zwergal; K Möhwald; M Dieterich
Journal:  Nervenarzt       Date:  2017-06       Impact factor: 1.214

Review 5.  Consensus Paper: Revisiting the Symptoms and Signs of Cerebellar Syndrome.

Authors:  Florian Bodranghien; Amy Bastian; Carlo Casali; Mark Hallett; Elan D Louis; Mario Manto; Peter Mariën; Dennis A Nowak; Jeremy D Schmahmann; Mariano Serrao; Katharina Marie Steiner; Michael Strupp; Caroline Tilikete; Dagmar Timmann; Kim van Dun
Journal:  Cerebellum       Date:  2016-06       Impact factor: 3.847

Review 6.  Aminopyridines for the treatment of neurologic disorders.

Authors:  Michael Strupp; Julian Teufel; Andreas Zwergal; Roman Schniepp; Kamran Khodakhah; Katharina Feil
Journal:  Neurol Clin Pract       Date:  2017-02

7.  Downbeat nystagmus and lower motor neuron disease: 14 years follow-up.

Authors:  E Anagnostou; G Papadimas; M Rentzos; T Zambelis
Journal:  J Neurol       Date:  2018-02-02       Impact factor: 4.849

8.  [Diagnosis and treatment options in vertigo syndromes].

Authors:  M Strupp; M Dieterich; A Zwergal; T Brandt
Journal:  Nervenarzt       Date:  2015-10       Impact factor: 1.214

9.  4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury.

Authors:  Kuang-Ching Tseng; Haiyan Li; Andrew Clark; Leigh Sundem; Michael Zuscik; Mark Noble; John Elfar
Journal:  EMBO Mol Med       Date:  2016-12-01       Impact factor: 12.137

Review 10.  Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and Treatment.

Authors:  Alessandro Serra; Clara G Chisari; Manuela Matta
Journal:  Front Neurol       Date:  2018-02-05       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.